Emerging Therapy Solutions

Emerging Therapy Solutions

Emerging Therapy Solutions provides analytical software tools and outsourced services to insurance providers and other payers to manage expensive cell and gene therapies. At Emerging Therapy Solutions (ETS), we provide the crucial insights, expert data and analysis, and comprehensive support payers need to contain the immense costs, forecasting potential risks associated with treating rare and complex medical conditions.

Total funding
~$16M
HQ 🇺🇸
Minneapolis, United States
Year founded
2018
Status
Alive
People
David J McLean
Chief Executive Officer
Nathan Schmidt
Chief Financial Officer
L. Matthew Knutson
Chief Information Officer
Investors
Telegraph Hill Partners
Categories
Share
Get access to exclusive data about Emerging Therapy Solutions
Access Emerging Therapy Solutions now